MIRA Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $11,161 | $0 | $0 |
Gross Profit | -2,081 | |||
EBITDA | -1,546 | -1,805 | -2,437 | -2,081 |
EBIT | -1,546 | -2,361 | -2,437 | -4,163 |
Net Income | -1,537 | -1,783 | -2,399 | -2,043 |
Net Change In Cash | 0 | 11,161 | 0 | 0 |
Free Cash Flow | -799 | -1,630 | -1,805 | -1,842 |
Cash | 730 | 1,206 | 2,832 | 4,144 |
Basic Shares | 16,986 | 16,645 | 15,258 | 15,071 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -8,526 | |||
EBITDA | -7,852 | -3,456 | -7,047 | -2,152 |
EBIT | -7,686 | -11,982 | -7,047 | -2,152 |
Net Income | -7,852 | -11,982 | -7,058 | -2,176 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,560 | -4 | -5,604 | -1,376 |
Cash | 2,832 | 4,602 | 350 | 2,809 |
Basic Shares | 15,444 | 18,566 | 14,745 | 14,745 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.10 |
2025-03-31 | -$0.11 |
2024-12-31 | -$0.17 |
